Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedFooter now shows Revision: v3.6.3, replacing v3.6.2, indicating a newer version of the page.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the ClinicalTrials.gov page. The update appears to be a metadata refresh rather than a substantive change to study details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAn explicit recruitment-status line 'No longer looking for participants' was added, indicating that the study is no longer seeking enrollees. In addition, there are minor navigation and formatting updates, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and a formatting tweak to the Intervention/Treatment heading.SummaryDifference0.4%

- Check35 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a minor update behind the scenes. There are no visible changes to the study details, layout, or user-facing content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe sponsor line for the MOR106 study was updated to Lakefront Biotherapeutics NV, and Galapagos NV was removed, indicating a shift in the organization responsible for the trial.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer version of the page template or documentation being used.SummaryDifference0.0%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.